Cyclezyme’s Olsson tops 5% stake after placement dilution triggers disclosures

• Cyclezyme’s directed share issue on July 7, 2026 raised total shares to 2,818,496 from 2,589,929, triggering voting-rights disclosures.
• Peter Falck’s stake stayed at 394,000 shares, diluted to 13.98% from 15.21%, falling below the 15% threshold.
• Javier Linares Pastén’s holding remained 394,000 shares, diluted to 13.98% from 15.21%, also dropping below 15%.
• Jens Olsson increased his holding to 175,261 shares from 118,119, lifting his stake to 6.22% from 4.56%, crossing 5%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclezyme AB published the original content used to generate this news brief via Cision (Ref. ID: 202608100348BITN____UKPR__SV_20260804-BIT-3948-0) on August 10, 2026, and is solely responsible for the information contained therein.